Skip Nav Destination
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
How I treat acute myeloid leukemia
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy
Issue Archive
October 28 2010
In this Issue
Table of Contents
Inside blood
Plenary paper
Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
CME
Clinical Trials & Observations
Can-Lan Sun,Liton Francisco,Toana Kawashima,Wendy Leisenring,Leslie L. Robison,K. Scott Baker,Daniel J. Weisdorf,Stephen J. Forman,Smita Bhatia
Review Article
How I treat
How I treat acute myeloid leukemia
Clinical Trials & Observations
Hematopoiesis and Stem Cells
Immunobiology
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
Clinical Trials & Observations
Sigbjørn Berentsen,Ulla Randen,Anne Marita Vågan,Henrik Hjorth-Hansen,Anders Vik,Jakob Dalgaard,Eva-Marie Jacobsen,Aud S. Thoresen,Klaus Beiske,Geir E. Tjønnfjord
ITAM signaling in dendritic cells controls T helper cell priming by regulating MHC class II recycling
Daniel B. Graham,Holly M. Akilesh,Grzegorz B. Gmyrek,Laura Piccio,Susan Gilfillan,Julia Sim,Roger Belizaire,Javier A. Carrero,Yinan Wang,Gregory S. Blaufuss,Gabriel Sandoval,Keiko Fujikawa,Anne H. Cross,John H. Russell,Marina Cella,Wojciech Swat
Impaired Epstein-Barr virus–specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family–positive B-cell targets
Andrew D. Hislop,Umaimainthan Palendira,Alison M. Leese,Peter D. Arkwright,Pierre S. Rohrlich,Stuart G. Tangye,H. Bobby Gaspar,Arjan C. Lankester,Alessandro Moretta,Alan B. Rickinson
Lymphoid Neoplasia
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
Güllü Görgün,Elisabetta Calabrese,Ender Soydan,Teru Hideshima,Giulia Perrone,Madhavi Bandi,Diana Cirstea,Loredana Santo,Yiguo Hu,Yu-Tzu Tai,Sabikun Nahar,Naoya Mimura,Claire Fabre,Noopur Raje,Nikhil Munshi,Paul Richardson,Kenneth C. Anderson
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Michael R. Green,Stefano Monti,Scott J. Rodig,Przemyslaw Juszczynski,Treeve Currie,Evan O'Donnell,Bjoern Chapuy,Kunihiko Takeyama,Donna Neuberg,Todd R. Golub,Jeffery L. Kutok,Margaret A. Shipp
Myeloid Neoplasia
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission
Clinical Trials & Observations
Norbert-Claude Gorin,Myriam Labopin,Josy Reiffers,Noel Milpied,Didier Blaise,Francis Witz,Theo de Witte,Giovanna Meloni,Michel Attal,Teresa Bernal,Vanderson Rocha,for the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
Clinical Trials & Observations
Francesco Lo-Coco,Giuseppe Avvisati,Marco Vignetti,Massimo Breccia,Eugenio Gallo,Alessandro Rambaldi,Francesca Paoloni,Giuseppe Fioritoni,Felicetto Ferrara,Giorgina Specchia,Giuseppe Cimino,Daniela Diverio,Erika Borlenghi,Giovanni Martinelli,Francesco Di Raimondo,Eros Di Bona,Paola Fazi,Antonio Peta,Alberto Bosi,Angelo M. Carella,Francesco Fabbiano,Enrico M. Pogliani,Maria C. Petti,Sergio Amadori,Franco Mandelli,for the Italian GIMEMA Cooperative Group
Phagocytes, Granulocytes, and Myelopoiesis
Platelets and Thrombopoiesis
Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy
Clinical Trials & Observations
Hagop M. Kantarjian,Francis J. Giles,Peter L. Greenberg,Ron L. Paquette,Eunice S. Wang,Janice L. Gabrilove,Guillermo Garcia-Manero,Kuolung Hu,Janet L. Franklin,Dietmar P. Berger
Red Cells, Iron, and Erythropoiesis
Thrombosis and Hemostasis
Vascular Biology
Role of synectin in lymphatic development in zebrafish and frogs
Karlien Hermans,Filip Claes,Wouter Vandevelde,Wei Zheng,Ilse Geudens,Fabrizio Orsenigo,Frederik De Smet,Evisa Gjini,Kristof Anthonis,Bin Ren,Dontcho Kerjaschki,Monica Autiero,Annelii Ny,Michael Simons,Mieke Dewerchin,Stefan Schulte-Merker,Elisabetta Dejana,Kari Alitalo,Peter Carmeliet
Correspondence
Other Departments
-
Cover Image
Cover Image
![issue cover]()
(Left) Electron microscopic image of an erythroblast undergoing enucleation. Note the accumulation of vesicles and vacuoles in the region of separation. (Right) Schematic illustration of the process of enucleation. Colored lines indicate membranes derived from vacuoles; the red line denotes the plasma membrane formed along the nuclear side after fusion of vesicles, while green depicts the fused vesicles along the reticulocyte boundary. See the article by Keerthivasan et al on page 3331.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
